CN Stock MarketDetailed Quotes

300725 PharmaBlock Sciences

Watchlist

31.77
-0.64-1.97%

Market Closed May 9 15:00 CST

6.35BMarket Cap30.81P/E (TTM)

PharmaBlock Sciences Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

46.67%645.48M

-43.23%290.2M

-70.50%312.26M

-75.68%283.26M

-46.66%440.1M

-55.57%511.19M

48.76%1.06B

65.42%1.16B

18.21%825.14M

64.43%1.15B

Transactional financial assets

34.00%295.47M

341.96%465.61M

58.25%284.28M

-22.84%110.94M

32.35%220.49M

-35.48%105.35M

-78.71%179.64M

-72.48%143.78M

-44.48%166.6M

-46.36%163.3M

Notes receivable and accounts receivable

-20.08%362.71M

1.73%481.8M

-11.61%398.72M

7.76%399.73M

42.05%453.87M

43.43%473.63M

37.64%451.08M

3.96%370.94M

21.62%319.51M

64.06%330.21M

-Accounts receivable

-20.08%362.71M

1.73%481.8M

-11.61%398.72M

7.76%399.73M

42.05%453.87M

43.43%473.63M

37.68%451.08M

4.25%370.94M

21.62%319.51M

64.06%330.21M

Other receivables (including interest and dividends)

34.93%1.94M

-26.98%1.92M

386.79%7.1M

345.12%6.29M

-5.84%1.44M

43.01%2.62M

-53.26%1.46M

-68.13%1.41M

-34.11%1.53M

-12.91%1.83M

-Other receivable

----

345.12%6.29M

----

43.01%2.62M

----

-68.13%1.41M

----

-12.91%1.83M

Advance payment

-45.78%7.03M

-48.59%6.14M

-36.86%6.66M

-41.58%7.14M

-35.63%12.96M

-8.05%11.94M

-64.91%10.54M

-58.47%12.22M

-24.83%20.14M

-45.56%12.99M

Inventories

1.73%780.9M

15.92%840.17M

22.34%909.48M

9.99%823.3M

7.75%767.65M

7.16%724.79M

13.75%743.42M

28.87%748.55M

27.93%712.47M

51.00%676.39M

Receivable financing

10.91%1.96M

6,199.53%1.89M

-86.82%100K

782.00%1.76M

-92.58%30K

--758.9K

--200K

--404.22K

Other current assets

-21.99%618.48M

-36.33%629.22M

65.73%770.31M

98.38%842.89M

11.53%792.82M

204.75%988.2M

27.49%464.8M

30.91%424.87M

359.22%710.84M

159.89%324.26M

Total current assets

0.85%2.71B

-3.58%2.72B

-7.60%2.69B

-13.73%2.47B

-2.37%2.69B

5.94%2.82B

-0.82%2.91B

13.67%2.87B

37.71%2.76B

47.44%2.66B

Non Current assets

Other equity investment

215.64%15.76M

215.94%15.78M

0.00%4.99M

11.13%4.99M

19.08%4.99M

7.15%4.49M

276.55%4.49M

Long-term equity investment

672.22%3.78M

734.54%4.09M

-52.19%548.91K

-64.31%386.3K

-46.73%489.57K

-58.03%489.57K

-42.60%1.15M

-78.41%1.08M

-84.91%919.09K

-84.88%1.17M

Fixed assets

----

13.54%1.49B

----

14.67%1.49B

----

37.69%1.31B

----

118.69%1.3B

Constru in process

----

-44.25%229.01M

----

-28.33%256.23M

----

-10.30%410.75M

----

-37.85%357.53M

Intangible assets

-1.48%106.54M

-1.31%107.98M

-1.95%106.65M

-1.66%107.67M

-2.25%108.14M

-1.85%109.42M

-1.33%108.77M

-0.81%109.49M

-0.54%110.63M

0.01%111.48M

Goodwill

-0.12%355.74M

0.00%356.19M

Long deferred expense

-34.91%6.25M

-31.56%6.94M

0.73%7.93M

-3.32%8.27M

17.57%9.6M

10.51%10.14M

-12.83%7.88M

-16.46%8.55M

31.30%8.16M

26.74%9.18M

Deferred tax assets

3.69%35.34M

-15.49%32.63M

-14.26%35M

-18.31%33.76M

-13.18%34.08M

7.85%38.61M

146.00%40.82M

115.54%41.32M

124.20%39.25M

137.14%35.8M

Usufruct assets

207.33%5.28M

90.79%4.14M

57.64%3.5M

57.19%4.19M

-45.23%1.72M

--2.17M

396.60%2.22M

197.96%2.67M

133.33%3.13M

----

Other non current assets

66.90%13.44M

-16.08%10.99M

-34.48%12.55M

-46.81%17.23M

-70.55%8.05M

-42.55%13.1M

-76.96%19.15M

-54.97%32.4M

-32.67%27.34M

-25.82%22.8M

Total non current assets

-3.08%2.2B

-2.97%2.22B

-3.46%2.23B

-1.20%2.25B

1.03%2.27B

3.81%2.29B

14.10%2.31B

14.59%2.28B

22.56%2.25B

29.33%2.2B

Total assets

-0.95%4.91B

-3.31%4.94B

-5.77%4.92B

-8.18%4.73B

-0.84%4.96B

4.97%5.1B

5.27%5.22B

14.08%5.15B

30.46%5B

38.65%4.86B

Liabilities

Current liabilities

Short term loan

306.81%230.19M

-2.64%230.27M

-22.40%230.01M

-99.96%110K

-79.62%56.59M

44.74%236.5M

-59.08%296.42M

-33.03%263M

-43.87%277.61M

-53.00%163.4M

Transactional financial liabilities

-97.97%3.35K

----

-99.06%457.73K

-99.86%53.6K

-97.07%165K

47.97%8.34M

36.49%48.7M

131.15%38.7M

1,430.60%5.64M

Notes payable and accounts payable

-15.97%259.14M

4.84%292.2M

-3.59%284.36M

-16.60%275.89M

-9.74%308.38M

-32.59%278.7M

-10.50%294.95M

-12.00%330.8M

-10.03%341.67M

54.66%413.47M

-Notes payable

-28.38%58.7M

-38.43%52.52M

-33.53%50.92M

-49.30%55.22M

-37.77%81.95M

-37.93%85.3M

-54.84%76.61M

-36.81%108.9M

-35.22%131.69M

-9.36%137.43M

-Accounts payable

-11.48%200.44M

23.93%239.69M

6.91%233.44M

-0.55%220.67M

7.83%226.43M

-29.94%193.41M

36.55%218.34M

9.01%221.9M

18.99%209.98M

138.54%276.04M

Contract liabilities

100.63%97.82M

72.28%56.12M

86.26%63.81M

24.56%45.98M

1.80%48.76M

-17.47%32.58M

-23.35%34.26M

-14.35%36.91M

67.56%47.9M

38.65%39.47M

Advance receipts

18.54%185.71K

0.00%156.67K

--280.92K

--119.52K

--156.67K

-2.47%156.67K

----

-28.98%160.63K

Salaries payable

7.29%46.98M

5.38%82.48M

-8.30%71.26M

-6.60%59.31M

-2.46%43.79M

-2.36%78.27M

9.31%77.71M

26.26%63.5M

36.69%44.89M

50.92%80.16M

Taxs payable

11.96%31.25M

-37.93%27.2M

12.92%22.16M

-20.90%17.21M

197.38%27.92M

321.45%43.82M

47.74%19.62M

154.50%21.76M

-10.62%9.39M

61.41%10.4M

Other payable (including interest and dividends)

-52.80%3.05M

52.78%4.64M

48.50%7.65M

-20.07%2.9M

-15.32%6.47M

-55.70%3.04M

-87.51%5.15M

-91.72%3.63M

-89.59%7.64M

-90.68%6.85M

-Other payable

----

-20.07%2.9M

----

-55.70%3.04M

----

-91.72%3.63M

----

-90.68%6.85M

Non current liabilities due within one year

-96.77%12.07M

-85.54%54M

-46.85%123.68M

9,676.28%206.78M

1,795.56%374.32M

2,059.68%373.41M

1,511.78%232.7M

-85.85%2.12M

65.07%19.75M

76.97%17.29M

Other current liabilities

8.06%2.49M

69.39%2.17M

50.00%2.68M

-19.10%1.31M

-20.03%2.3M

-45.08%1.28M

-49.41%1.79M

-53.60%1.62M

15.22%2.88M

16.60%2.33M

Total current liabilities

-21.37%683.19M

-29.06%749.23M

-20.27%806.34M

-20.00%609.67M

14.72%868.84M

42.87%1.06B

-20.86%1.01B

-19.76%762.04M

-26.81%757.36M

-6.30%739.18M

Current liabilities

Long term loan

----

-91.78%20.01M

-85.69%67.77M

-87.97%47.74M

-85.57%50.03M

869.69%243.5M

1,785.62%473.5M

1,214.46%396.74M

1,368.99%346.74M

Bonds payable

3.37%1.14B

3.50%1.13B

3.82%1.12B

3.95%1.11B

4.05%1.1B

4.09%1.09B

4.17%1.08B

4.23%1.07B

--1.06B

--1.05B

Long term account payable

----

--0

----

--0

----

--0

----

--0

Specific account payable

----

0.00%900K

----

100.00%900K

----

100.00%900K

----

0.00%450K

Deferred tax liabilities

7.51%21.54M

-8.97%22.13M

15.16%21.64M

15.55%22.24M

1.69%20.04M

20.64%24.31M

61.96%18.79M

61.33%19.25M

62.31%19.71M

60.18%20.15M

Long term deferred income

-11.04%44.52M

-11.64%45.71M

-12.43%46.98M

-11.58%48.67M

-1.73%50.05M

-1.27%51.74M

2.15%53.65M

2.00%55.04M

-2.61%50.93M

-2.40%52.4M

Lease liabilities

1,586.19%4.37M

1,304.60%3.21M

-69.87%534.31K

-46.93%987.95K

-85.52%259.37K

--228.27K

--1.77M

--1.86M

--1.79M

----

Total non current liabilities

-0.87%1.21B

-1.41%1.2B

-13.42%1.21B

-22.74%1.25B

-20.18%1.22B

-17.04%1.22B

24.20%1.4B

45.04%1.62B

1,505.18%1.53B

1,522.33%1.47B

Total liabilities

-9.40%1.89B

-14.26%1.95B

-16.30%2.02B

-21.86%1.86B

-8.60%2.09B

3.05%2.27B

0.23%2.41B

15.24%2.38B

102.10%2.28B

150.74%2.2B

Shareholders equity

Paid-in capital

0.03%199.73M

0.00%199.67M

0.00%199.66M

-0.02%199.66M

Other equity instruments

-0.19%126.36M

-0.00%126.6M

-0.05%126.6M

--126.6M

Capital reserve funds

0.30%1.1B

0.51%1.1B

0.85%1.1B

0.99%1.1B

1.07%1.09B

1.44%1.09B

2.04%1.09B

2.67%1.09B

-17.00%1.08B

-17.26%1.07B

Surplus reserve funds

0.00%99.83M

2.92%99.83M

30.59%97M

Retained profit

10.39%1.53B

11.79%1.5B

8.53%1.41B

9.36%1.38B

13.61%1.39B

14.99%1.34B

15.68%1.3B

22.65%1.26B

26.82%1.22B

30.41%1.16B

Less:Treasury stock

0.00%30.04M

49.96%30.04M

--30.04M

--20.03M

----

Other composite income

38.43%-1.98M

45.59%-1.83M

-119.70%-4.42M

-178.13%-2.75M

47.47%-3.21M

31.07%-3.35M

35.31%-2.01M

66.74%-989.51K

-66.22%-6.12M

-41.45%-4.87M

Specific reserves

91.27%1.02M

153.74%701.95K

1,158.52%1.02M

-42.08%699.6K

--535.54K

--276.64K

--81.27K

--1.21M

----

Shareholders equity without minority interests

5.18%3.02B

5.48%2.99B

3.25%2.9B

3.58%2.87B

5.66%2.88B

6.57%2.83B

10.01%2.81B

13.09%2.77B

8.74%2.72B

9.48%2.66B

Minority interests

----

-246.68%-8.61

-186.62%-8.61

-100.00%-2.54

-100.00%5.86

Total shareholder equity

5.18%3.02B

5.48%2.99B

3.25%2.9B

3.58%2.87B

5.66%2.88B

6.57%2.83B

10.01%2.81B

13.09%2.77B

0.55%2.72B

1.14%2.66B

Total liabilityies and equity

-0.95%4.91B

-3.31%4.94B

-5.77%4.92B

-8.18%4.73B

-0.84%4.96B

4.97%5.1B

5.27%5.22B

14.08%5.15B

30.46%5B

38.65%4.86B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Notarized Tianye Certified Public Accountants Firm (Special General Partnership)

Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	46.67%645.48M	-43.23%290.2M	-70.50%312.26M	-75.68%283.26M	-46.66%440.1M	-55.57%511.19M	48.76%1.06B	65.42%1.16B	18.21%825.14M	64.43%1.15B
Transactional financial assets	34.00%295.47M	341.96%465.61M	58.25%284.28M	-22.84%110.94M	32.35%220.49M	-35.48%105.35M	-78.71%179.64M	-72.48%143.78M	-44.48%166.6M	-46.36%163.3M
Notes receivable and accounts receivable	-20.08%362.71M	1.73%481.8M	-11.61%398.72M	7.76%399.73M	42.05%453.87M	43.43%473.63M	37.64%451.08M	3.96%370.94M	21.62%319.51M	64.06%330.21M
-Accounts receivable	-20.08%362.71M	1.73%481.8M	-11.61%398.72M	7.76%399.73M	42.05%453.87M	43.43%473.63M	37.68%451.08M	4.25%370.94M	21.62%319.51M	64.06%330.21M
Other receivables (including interest and dividends)	34.93%1.94M	-26.98%1.92M	386.79%7.1M	345.12%6.29M	-5.84%1.44M	43.01%2.62M	-53.26%1.46M	-68.13%1.41M	-34.11%1.53M	-12.91%1.83M
-Other receivable	----	----	----	345.12%6.29M	----	43.01%2.62M	----	-68.13%1.41M	----	-12.91%1.83M
Advance payment	-45.78%7.03M	-48.59%6.14M	-36.86%6.66M	-41.58%7.14M	-35.63%12.96M	-8.05%11.94M	-64.91%10.54M	-58.47%12.22M	-24.83%20.14M	-45.56%12.99M
Inventories	1.73%780.9M	15.92%840.17M	22.34%909.48M	9.99%823.3M	7.75%767.65M	7.16%724.79M	13.75%743.42M	28.87%748.55M	27.93%712.47M	51.00%676.39M
Receivable financing	10.91%1.96M	6,199.53%1.89M	-86.82%100K	-86.82%100K	782.00%1.76M	-92.58%30K	--758.9K	--758.9K	--200K	--404.22K
Other current assets	-21.99%618.48M	-36.33%629.22M	65.73%770.31M	98.38%842.89M	11.53%792.82M	204.75%988.2M	27.49%464.8M	30.91%424.87M	359.22%710.84M	159.89%324.26M
Total current assets	0.85%2.71B	-3.58%2.72B	-7.60%2.69B	-13.73%2.47B	-2.37%2.69B	5.94%2.82B	-0.82%2.91B	13.67%2.87B	37.71%2.76B	47.44%2.66B
Non Current assets
Other equity investment	215.64%15.76M	215.94%15.78M	0.00%4.99M	11.13%4.99M	11.13%4.99M	11.13%4.99M	19.08%4.99M	7.15%4.49M	7.15%4.49M	276.55%4.49M
Long-term equity investment	672.22%3.78M	734.54%4.09M	-52.19%548.91K	-64.31%386.3K	-46.73%489.57K	-58.03%489.57K	-42.60%1.15M	-78.41%1.08M	-84.91%919.09K	-84.88%1.17M
Fixed assets	----	----	----	13.54%1.49B	----	14.67%1.49B	----	37.69%1.31B	----	118.69%1.3B
Constru in process	----	----	----	-44.25%229.01M	----	-28.33%256.23M	----	-10.30%410.75M	----	-37.85%357.53M
Intangible assets	-1.48%106.54M	-1.31%107.98M	-1.95%106.65M	-1.66%107.67M	-2.25%108.14M	-1.85%109.42M	-1.33%108.77M	-0.81%109.49M	-0.54%110.63M	0.01%111.48M
Goodwill	-0.12%355.74M	-0.12%355.74M	0.00%356.19M	0.00%356.19M	0.00%356.19M	0.00%356.19M	0.00%356.19M	0.00%356.19M	0.00%356.19M	0.00%356.19M
Long deferred expense	-34.91%6.25M	-31.56%6.94M	0.73%7.93M	-3.32%8.27M	17.57%9.6M	10.51%10.14M	-12.83%7.88M	-16.46%8.55M	31.30%8.16M	26.74%9.18M
Deferred tax assets	3.69%35.34M	-15.49%32.63M	-14.26%35M	-18.31%33.76M	-13.18%34.08M	7.85%38.61M	146.00%40.82M	115.54%41.32M	124.20%39.25M	137.14%35.8M
Usufruct assets	207.33%5.28M	90.79%4.14M	57.64%3.5M	57.19%4.19M	-45.23%1.72M	--2.17M	396.60%2.22M	197.96%2.67M	133.33%3.13M	----
Other non current assets	66.90%13.44M	-16.08%10.99M	-34.48%12.55M	-46.81%17.23M	-70.55%8.05M	-42.55%13.1M	-76.96%19.15M	-54.97%32.4M	-32.67%27.34M	-25.82%22.8M
Total non current assets	-3.08%2.2B	-2.97%2.22B	-3.46%2.23B	-1.20%2.25B	1.03%2.27B	3.81%2.29B	14.10%2.31B	14.59%2.28B	22.56%2.25B	29.33%2.2B
Total assets	-0.95%4.91B	-3.31%4.94B	-5.77%4.92B	-8.18%4.73B	-0.84%4.96B	4.97%5.1B	5.27%5.22B	14.08%5.15B	30.46%5B	38.65%4.86B
Liabilities
Current liabilities
Short term loan	306.81%230.19M	-2.64%230.27M	-22.40%230.01M	-99.96%110K	-79.62%56.59M	44.74%236.5M	-59.08%296.42M	-33.03%263M	-43.87%277.61M	-53.00%163.4M
Transactional financial liabilities	-97.97%3.35K	----	-99.06%457.73K	-99.86%53.6K	-97.07%165K	47.97%8.34M	36.49%48.7M	131.15%38.7M	1,430.60%5.64M	1,430.60%5.64M
Notes payable and accounts payable	-15.97%259.14M	4.84%292.2M	-3.59%284.36M	-16.60%275.89M	-9.74%308.38M	-32.59%278.7M	-10.50%294.95M	-12.00%330.8M	-10.03%341.67M	54.66%413.47M
-Notes payable	-28.38%58.7M	-38.43%52.52M	-33.53%50.92M	-49.30%55.22M	-37.77%81.95M	-37.93%85.3M	-54.84%76.61M	-36.81%108.9M	-35.22%131.69M	-9.36%137.43M
-Accounts payable	-11.48%200.44M	23.93%239.69M	6.91%233.44M	-0.55%220.67M	7.83%226.43M	-29.94%193.41M	36.55%218.34M	9.01%221.9M	18.99%209.98M	138.54%276.04M
Contract liabilities	100.63%97.82M	72.28%56.12M	86.26%63.81M	24.56%45.98M	1.80%48.76M	-17.47%32.58M	-23.35%34.26M	-14.35%36.91M	67.56%47.9M	38.65%39.47M
Advance receipts	18.54%185.71K	0.00%156.67K	--280.92K	--119.52K	--156.67K	-2.47%156.67K	----	----	----	-28.98%160.63K
Salaries payable	7.29%46.98M	5.38%82.48M	-8.30%71.26M	-6.60%59.31M	-2.46%43.79M	-2.36%78.27M	9.31%77.71M	26.26%63.5M	36.69%44.89M	50.92%80.16M
Taxs payable	11.96%31.25M	-37.93%27.2M	12.92%22.16M	-20.90%17.21M	197.38%27.92M	321.45%43.82M	47.74%19.62M	154.50%21.76M	-10.62%9.39M	61.41%10.4M
Other payable (including interest and dividends)	-52.80%3.05M	52.78%4.64M	48.50%7.65M	-20.07%2.9M	-15.32%6.47M	-55.70%3.04M	-87.51%5.15M	-91.72%3.63M	-89.59%7.64M	-90.68%6.85M
-Other payable	----	----	----	-20.07%2.9M	----	-55.70%3.04M	----	-91.72%3.63M	----	-90.68%6.85M
Non current liabilities due within one year	-96.77%12.07M	-85.54%54M	-46.85%123.68M	9,676.28%206.78M	1,795.56%374.32M	2,059.68%373.41M	1,511.78%232.7M	-85.85%2.12M	65.07%19.75M	76.97%17.29M
Other current liabilities	8.06%2.49M	69.39%2.17M	50.00%2.68M	-19.10%1.31M	-20.03%2.3M	-45.08%1.28M	-49.41%1.79M	-53.60%1.62M	15.22%2.88M	16.60%2.33M
Total current liabilities	-21.37%683.19M	-29.06%749.23M	-20.27%806.34M	-20.00%609.67M	14.72%868.84M	42.87%1.06B	-20.86%1.01B	-19.76%762.04M	-26.81%757.36M	-6.30%739.18M
Current liabilities
Long term loan	----	----	-91.78%20.01M	-85.69%67.77M	-87.97%47.74M	-85.57%50.03M	869.69%243.5M	1,785.62%473.5M	1,214.46%396.74M	1,368.99%346.74M
Bonds payable	3.37%1.14B	3.50%1.13B	3.82%1.12B	3.95%1.11B	4.05%1.1B	4.09%1.09B	4.17%1.08B	4.23%1.07B	--1.06B	--1.05B
Long term account payable	----	----	----	--0	----	--0	----	--0	----	--0
Specific account payable	----	----	----	0.00%900K	----	100.00%900K	----	100.00%900K	----	0.00%450K
Deferred tax liabilities	7.51%21.54M	-8.97%22.13M	15.16%21.64M	15.55%22.24M	1.69%20.04M	20.64%24.31M	61.96%18.79M	61.33%19.25M	62.31%19.71M	60.18%20.15M
Long term deferred income	-11.04%44.52M	-11.64%45.71M	-12.43%46.98M	-11.58%48.67M	-1.73%50.05M	-1.27%51.74M	2.15%53.65M	2.00%55.04M	-2.61%50.93M	-2.40%52.4M
Lease liabilities	1,586.19%4.37M	1,304.60%3.21M	-69.87%534.31K	-46.93%987.95K	-85.52%259.37K	--228.27K	--1.77M	--1.86M	--1.79M	----
Total non current liabilities	-0.87%1.21B	-1.41%1.2B	-13.42%1.21B	-22.74%1.25B	-20.18%1.22B	-17.04%1.22B	24.20%1.4B	45.04%1.62B	1,505.18%1.53B	1,522.33%1.47B
Total liabilities	-9.40%1.89B	-14.26%1.95B	-16.30%2.02B	-21.86%1.86B	-8.60%2.09B	3.05%2.27B	0.23%2.41B	15.24%2.38B	102.10%2.28B	150.74%2.2B
Shareholders equity
Paid-in capital	0.03%199.73M	0.03%199.73M	0.00%199.67M	0.00%199.66M	0.00%199.66M	0.00%199.66M	0.00%199.66M	0.00%199.66M	-0.02%199.66M	-0.02%199.66M
Other equity instruments	-0.19%126.36M	-0.19%126.36M	-0.00%126.6M	-0.00%126.6M	-0.00%126.6M	-0.00%126.6M	-0.05%126.6M	-0.05%126.6M	--126.6M	--126.6M
Capital reserve funds	0.30%1.1B	0.51%1.1B	0.85%1.1B	0.99%1.1B	1.07%1.09B	1.44%1.09B	2.04%1.09B	2.67%1.09B	-17.00%1.08B	-17.26%1.07B
Surplus reserve funds	0.00%99.83M	0.00%99.83M	2.92%99.83M	2.92%99.83M	2.92%99.83M	2.92%99.83M	30.59%97M	30.59%97M	30.59%97M	30.59%97M
Retained profit	10.39%1.53B	11.79%1.5B	8.53%1.41B	9.36%1.38B	13.61%1.39B	14.99%1.34B	15.68%1.3B	22.65%1.26B	26.82%1.22B	30.41%1.16B
Less:Treasury stock	0.00%30.04M	49.96%30.04M	--30.04M	--30.04M	--30.04M	--20.03M	----	----	----	----
Other composite income	38.43%-1.98M	45.59%-1.83M	-119.70%-4.42M	-178.13%-2.75M	47.47%-3.21M	31.07%-3.35M	35.31%-2.01M	66.74%-989.51K	-66.22%-6.12M	-41.45%-4.87M
Specific reserves	91.27%1.02M	153.74%701.95K	1,158.52%1.02M	-42.08%699.6K	--535.54K	--276.64K	--81.27K	--1.21M	----	----
Shareholders equity without minority interests	5.18%3.02B	5.48%2.99B	3.25%2.9B	3.58%2.87B	5.66%2.88B	6.57%2.83B	10.01%2.81B	13.09%2.77B	8.74%2.72B	9.48%2.66B
Minority interests	----	----	----	----	----	----	-246.68%-8.61	-186.62%-8.61	-100.00%-2.54	-100.00%5.86
Total shareholder equity	5.18%3.02B	5.48%2.99B	3.25%2.9B	3.58%2.87B	5.66%2.88B	6.57%2.83B	10.01%2.81B	13.09%2.77B	0.55%2.72B	1.14%2.66B
Total liabilityies and equity	-0.95%4.91B	-3.31%4.94B	-5.77%4.92B	-8.18%4.73B	-0.84%4.96B	4.97%5.1B	5.27%5.22B	14.08%5.15B	30.46%5B	38.65%4.86B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Notarized Tianye Certified Public Accountants Firm (Special General Partnership)	--	--	--	Notarized Tianye Certified Public Accountants Firm (Special General Partnership)	--	--	--	Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

300725 PharmaBlock Sciences

PharmaBlock Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course